Clinical trial
Smith-Lemli Opitz Syndrome: A Clinical Investigation of the Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
NCT01434745 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Smith-Lemli Opitz Syndrome: A Clinical Investigation of the Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
- Lead sponsor
- Oregon Health and Science University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 30, 2011
- Completion date
- October 31, 2014
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.